Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Oncotarget|February 9, 2018
LGR5 and LGR6 in stem cell biology and ovarian cancerAdam J Schindler, Arisa Watanabe, Stephen B Howell
Molecular Pharmacology|July 19, 2006
Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatinAlison K Holzer, Gerald H Manorek, Stephen B Howell
Plos One|June 28, 2013
Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4Xinjian Lin, Xiying Shang, Gerald Manorek, et al.
Molecular Pharmacology|February 24, 2006
Human REV1 modulates the cytotoxicity and mutagenicity of cisplatin in human ovarian carcinoma cellsXinjian Lin, Tsuyoshi Okuda, Julie Trang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repairXinjian Lin, Julie Trang, Tsuyoshi Okuda, et al.
Molecular Pharmacology|October 23, 2002
The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiaeXinjian Lin, Tsuyoshi Okuda, Alison Holzer, et al.
Molecular Pharmacology|March 11, 2005
Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatinTsuyoshi Okuda, Xinjian Lin, Julie Trang, et al.
Pageof 11